175
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Biofunctionalization of biomaterials for nitric oxide delivery: potential applications in regenerative medicine

, , &
Pages 25-36 | Published online: 27 Aug 2018

References

  • Tsai KJ, Dixon S, Hale LR, Darbyshire A, Martin D, de Mel A. Biomimetic heterogenous elastic tissue development. NPJ Regen Med. 2017;2:16.
  • Wang T, van der Vlies AJ, Uyama H, Hasegawa U. Nitric oxide-releasing polymeric furoxan conjugates. Polym Chem. 2015;6:7737–7748.
  • Garthwaite J. New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications. Mol Cell Biochem. 2010;334(1–2):221–232.
  • Moore C, Tymvios C, Emerson M. Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase. Thromb Haemost. 2010;104(2):342–349.
  • Ozuyaman B, Ebner P, Niesler U, et al. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost. 2005;94(4):770–772.
  • Parent M, Boudier A, Fries I, et al. Nitric oxide-eluting scaffolds and their interaction with smooth muscle cells in vitro. J Biomed Mater Res A. 2015;103(10):3303–3311.
  • de Mel A, Murad F, Seifalian AM. Nitric oxide: a guardian for vascular grafts? Chem Rev. 2011;111(9):5742–5767.
  • Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci. 2007;8(10):766–775.
  • Brisbois EJ, Davis RP, Jones AM, et al. Reduction in thrombosis and bacterial adhesion with 7 day implantation of S-nitroso-N-acetylpenicillamine (SNAP)-doped elast-eon E2As catheters in sheep. J Mater Chem B. 2015;3(8):1639–1645.
  • Engelsman AF, Krom BP, Busscher HJ, van Dam GM, Ploeg RJ, van der Mei HC. Antimicrobial effects of an NO-releasing poly(ethylene vinylacetate) coating on soft-tissue implants in vitro and in a murine model. Acta Biomater. 2009;5(6):1905–1910.
  • Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: a review. World J Surg Oncol. 2013;11:118.
  • Broniowska KA, Diers AR, Hogg N. S-nitrosoglutathione. Biochim Biophys Acta. 2013;1830(5):3173–3181.
  • Joslin JM, Lantvit SM, Reynolds MM. Nitric oxide releasing Tygon materials: studies in donor leaching and localized nitric oxide release at a polymer-buffer interface. ACS Appl Mater Interfaces. 2013;5(19):9285–9294.
  • Van Wagner M, Rhadigan J, Lancina M, et al. S-nitroso-N-acetylpenicillamine (SNAP) derivatization of peptide primary amines to create inducible nitric oxide donor biomaterials. ACS Appl Mater Interfaces. 2013;5(7):8430–8439.
  • Koh A, Carpenter AW, Slomberg DL, Schoenfisch MH. Nitric oxide-releasing silica nanoparticle-doped polyurethane electrospun fibers. ACS Appl Mater Interfaces. 2013;5(16):7956–7964.
  • Hwa Yu S, Hu J, Ercole F, et al. Transformation of RAFT polymer end groups into nitric oxide donor moieties: en route to biochemically active nanostructures. ACS Macro Lett. 2015;4(11):1278–1282.
  • Suchyta DJ, Schoenfisch MH. Encapsulation of N-diazeniumdiolates within liposomes for enhanced nitric oxide donor stability and delivery. Mol Pharm. 2015;12(10):3569–3574.
  • de Mel A, Naghavi N, Cousins BG, et al. Nitric oxide-eluting nanocomposite for cardiovascular implants. J Mater Sci Mater Med. 2014;25(3):917–929.
  • Everett W, Scurr DJ, Rammou A, Darbyshire A, Hamilton G, de Mel A. A material conferring hemocompatibility. Sci Rep. 2016;6:26848.
  • Stasko NA, Fischer TH, Schoenfisch MH. S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles. Biomacromolecules. 2008;9:834–841.
  • Liu H, Ding Y, Ao Z, Zhou Y, Wang S, Jiang L. Fabricating surfaces with tunable wettability and adhesion by ionic liquids in a wide range. Small. 2015;11(15):1782–1786.
  • Naghavi N, Seifalian AM, Hamilton G, de Mel A. Evaluation of experimental methods for nitric oxide release from cardiovascular implants; bypass grafts as an exemplar. Ther Adv Cardiovasc Dis. 2015;9(6):375–388.
  • Kobsar A, Simonis S, Klinker E, et al. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets. Eur J Pharmacol. 2014;735:169–176.
  • Riccio DA, Dobmeier KP, Hetrick EM, Privett BJ, Paul HS, Schoenfisch HM. Nitric oxide-releasing S-nitrosothiol-modified xerogels. Biomaterials. 2009;30(27):4494–4502.
  • Jo YS, Van Der Vlies A, Gantz J, et al. Micelles for delivery of nitric oxide. J Am Chem Soc. 2009;131(40):14413–14418.
  • Kumar V, Hong SY, Maciag AE, et al. Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and double JS-K, through incorporation into PEG-protected nanoparticles. Mol Pharm. 2010;7(1):291–298.
  • Duong HTT, Kamarudin ZM, Erlich RB, et al. Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers. Chem Commun (Camb). 2013;49(39):4190–4192.
  • Carpenter AW, Slomberg DL, Rao KS, Schoenfisch MH. Influence of scaffold size on bactericidal activity of nitric oxide releasing silica nanoparticles. ACS Nano. 2011;5(9):7235–7244.
  • Chaves C, Gao C, Hunckler J, et al. Dual-acting biofunctionalised scaffolds for applications in regenerative medicine. J Mater Sci Mater Med. 2017;28(2):32.